Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones

Paramount efforts by pharmaceutical industry to identify new targets for obesity-diabetes (Diabesity) pharmacological intervention have led to a number of agents developed and directed at DPP IV [dipeptidyl peptidase IV] enzyme inhibition thereby enhancing endogenous insulinotropic incretins. Beside...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabiyat, Shereen, Kasabri, Violet, Al-Hiari, Yusuf, AL-MASRI, Ihab, Alalawi, Sundus, Bustanji, Yasser K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852796/
https://www.ncbi.nlm.nih.gov/pubmed/31450926
http://dx.doi.org/10.31557/APJCP.2019.20.8.2503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852796/
https://www.ncbi.nlm.nih.gov/pubmed/31450926
http://dx.doi.org/10.31557/APJCP.2019.20.8.2503

Ejemplares similares